How could nanosensors help detect cancerous tumors at an early stage?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Nanosensors and nanoparticle-based technologies offer significant potential for the early detection of cancerous tumors by identifying specific biological signatures at the molecular level. Because of their small size, nanoparticles can circulate throughout the body and be engineered to bind to specific cells or disease states.12

Key methods for early detection include:

  • Enhanced Imaging: Nanoparticles can improve the contrast in medical imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound, allowing for more precise visualization of tumors. For example, superparamagnetic iron oxide particles are used to track the spread of cancer in lymph nodes.2
  • Bioassays: Researchers use nanoparticles as labels to detect specific biomolecules. Semiconductor nanoparticles can emit light of specific wavelengths, while magnetic nanoparticles can be attached to antibodies to identify and extract target molecules from small samples.1
  • Molecular Sensing: By threading DNA strands through nanoscale pores, scientists can measure changes in ion current to identify specific genetic sequences, facilitating rapid clinical analysis.1

These advancements in nanomedicine are critical for shifting toward earlier diagnosis and more personalized treatment strategies.12